1. Home
  2. YYAI vs MEIP Comparison

YYAI vs MEIP Comparison

Compare YYAI & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YYAI
  • MEIP
  • Stock Information
  • Founded
  • YYAI 2015
  • MEIP 2000
  • Country
  • YYAI United States
  • MEIP United States
  • Employees
  • YYAI N/A
  • MEIP N/A
  • Industry
  • YYAI
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • YYAI
  • MEIP Health Care
  • Exchange
  • YYAI NYSE
  • MEIP Nasdaq
  • Market Cap
  • YYAI 19.5M
  • MEIP 20.9M
  • IPO Year
  • YYAI N/A
  • MEIP 2003
  • Fundamental
  • Price
  • YYAI $6.10
  • MEIP $3.10
  • Analyst Decision
  • YYAI
  • MEIP Hold
  • Analyst Count
  • YYAI 0
  • MEIP 2
  • Target Price
  • YYAI N/A
  • MEIP $7.00
  • AVG Volume (30 Days)
  • YYAI 70.2K
  • MEIP 13.5K
  • Earning Date
  • YYAI 10-03-2024
  • MEIP 09-24-2024
  • Dividend Yield
  • YYAI N/A
  • MEIP N/A
  • EPS Growth
  • YYAI N/A
  • MEIP N/A
  • EPS
  • YYAI N/A
  • MEIP 3.93
  • Revenue
  • YYAI $8,398,049.00
  • MEIP $66,754,000.00
  • Revenue This Year
  • YYAI N/A
  • MEIP $36.44
  • Revenue Next Year
  • YYAI N/A
  • MEIP N/A
  • P/E Ratio
  • YYAI N/A
  • MEIP $0.79
  • Revenue Growth
  • YYAI N/A
  • MEIP 13.58
  • 52 Week Low
  • YYAI $2.90
  • MEIP $2.73
  • 52 Week High
  • YYAI $214.40
  • MEIP $7.87
  • Technical
  • Relative Strength Index (RSI)
  • YYAI 32.05
  • MEIP 45.60
  • Support Level
  • YYAI $5.66
  • MEIP $3.06
  • Resistance Level
  • YYAI $6.47
  • MEIP $3.33
  • Average True Range (ATR)
  • YYAI 1.00
  • MEIP 0.14
  • MACD
  • YYAI -0.05
  • MEIP -0.01
  • Stochastic Oscillator
  • YYAI 13.10
  • MEIP 23.33

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks: